Traders should monitor the integration progress, regulatory timelines for Robocath’s next-gen system, and milestone achievement potential. The deal significantly expands Stereotaxis’ commercial and technological footprint in high-growth robotic interventional markets, which could re-rate the stock if execution is strong.
Price Chart
Executive Summary
Stereotaxis (STXS) announced a definitive agreement to acquire Robocath, a French innovator in robotic interventional cardiology and neurointerventions, for $20 million upfront and up to $25 million in contingent milestone payments. The deal combines Stereotaxis’ magnetic navigation technology with Robocath’s mechanical robotic system, creating a broader endovascular robotics platform and accelerating entry into large interventional markets. The acquisition is expected to close in mid-2026 and become breakeven by year three.
Key Financial Metrics
Key Facts
- Stereotaxis is acquiring Robocath for $20 million upfront and up to $25 million in contingent payments tied to regulatory and commercial milestones.
- Robocath contributes approximately $2 million in annual revenue and is expected to reach breakeven by the third year post-acquisition.
- The combined platform integrates Stereotaxis' magnetic navigation with Robocath's multi-device mechanical robotics, targeting electrophysiology, interventional cardiology, and neurointerventions.
- Stereotaxis plans U.S. and European regulatory submissions for Robocath’s next-gen system within two years.
- The acquisition is expected to close in mid-2026, subject to customary conditions.
Financial Impact
$20 million upfront payment with up to $25 million in milestone payments; adds $2 million in annual revenue and expands market reach into multi-billion-dollar interventional markets.
Risk Factors
- Execution risk in integrating Robocath’s operations and technology.
- Failure to achieve FDA clearance or other milestones could limit contingent payout realization and delay revenue growth.
- Potential dilution if Stereotaxis elects to pay consideration in stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274290 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 7w ago | Press Release | $1.39 $1.18 | ▼ −15.11% | ▼ −13.92% | $0.9900 (−28.78%) |
Aug 14, 2026 10w ago | EFFECT | $1.38 $1.33 | ▲ +3.62% | ▲ +1.63% | $0.9900 (+28.26%) |
Aug 14, 2026 10w ago | EFFECT | $1.38 $1.33 | ▲ +3.62% | ▲ +1.63% | $0.9900 (+28.26%) |
Aug 11, 2026 10w ago | Press Release | $1.40 $1.30 | ▼ −7.14% | ▼ −5.25% | $0.9900 (−29.29%) |
Jul 15, 2026 14w ago | S-3 | $1.65 $1.38 | ▲ +16.36% | ▲ +19.98% | $0.9900 (+40.00%) |
Jul 15, 2026 14w ago | S-3 | $1.65 $1.38 | ▼ −16.36% | ▼ −19.98% | $0.9900 (−40.00%) |
Jul 9, 2026 15w ago | 8-K | $1.74 $1.36 | ▼ −21.84% | ▼ −24.08% | $0.9900 (−43.10%) |
May 12, 2026 23w ago | 8-K | $1.85 $1.82 | ▲ +1.62% | ▲ +1.01% | $0.9900 (+46.49%) |
May 12, 2026 23w ago | Press Release | $1.85 $1.82 | ▼ −1.62% | ▼ −1.01% | $0.9900 (−46.49%) |
Apr 21, 2026 26w ago | Press Release | $1.92 $1.78 | ▼ −7.29% | ▼ −12.21% | $0.9900 (−48.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers